Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1998

Punch JD, Tono T, Qin L, Bishop DK, Bromberg JS. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement. J Immunol. 1998;161(3):1156-62.

Ross JM, McIntire LV, Moake JL, Kuo HJ, Qian RQ, Glanville RW, et al. Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions. Thromb Haemost. 1998;79(1):155-61.

Macrì E, Loda M. Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev. 1998;17(4):337-44.

Siddiqui MT, Evans HL, Ro JY, Ayala AG. Epithelioid haemangioendothelioma of the thyroid gland: a case report and review of literature. Histopathology. 1998;32(5):473-6.

Jessup JM, Loda M. Prognostic markers in rectal carcinoma. Semin Surg Oncol. 1998;15(2):131-40.

Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, et al. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 1998;12(18):2899-911.

Magi-Galluzzi C, Montironi R, Cangi MG, Wishnow K, Loda M. Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch. 1998;432(5):407-13.

Hsu HY, Hajjar DP, Khan KM, Falcone DJ. Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem. 1998;273(2):1240-6.

Bao L, Loda M, Zetter BR. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis. 1998;16(3):227-33.

Berra E, Diaz-Meco MT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem. 1998;273(17):10792-7.